Candidaemia in patients with haematological disorders and stem cell transplant

References

• Abi-Said D, Anaissie E, Uzun O, Raad I, Pinzcowski H, Vartivarian S. The epidemiology of hematogenous candidiasis caused by different Candida species. Olin Infect Dis 1997; 24:1122–1128.
   PubMed Web of Science ®Google Scholar
• Viscoli C, Girmenia C, Marinus A, Collete L, Martino P, Vandercam B, Doyen C, Lebeau B, Spence D, Krc-mery V, De Pauw B, Meunier F and the Invasive Fungal Infection Group of the EORTC. Candidemia in cancer patients:a prospective multicenter surveillance study by the Invasive Fungal Infection Group (IFIG) of the Europian Organization for Research and Treatment of Cancer (EORTC) . Olin Infect Dis 1999; 28:1071-1079.
   PubMed Web of Science ®Google Scholar
• Slavin M A and the Australian Mycology Interest Group. The epidemiology of candidaemia and mould infections in Australia. J Antimicrob Chemother 2002; 49:3–6.
   PubMed Web of Science ®Google Scholar
• Swinne D, Watelle M, Suetens C, Martens K, Fonteyne PA, Nolard N. A one-year survey of candidemia in Belgium in 2002. Epidemiol Infect 2004; 132:1175-1180.
   Google Scholar
• Pagano L, Antinori A, Ammassari A, Mele L, Nosari A, Melillo L, Martino B, Sanguinetti M, Equitani F, Nobile F, Cartotenuto M, Morra E, Morace G, Leone G. Retrospective study of candidemia in patients with hematological malignancies. Clinical features, risk factors and outcome of 76 episodes. Eur J Haematol 1999; 63:77–85.
   Google Scholar
• Laverdiere M, Rotstein C, Bow EJ, Roberts RS, loannou S, Carr D, Moghaddam N and the Canadian Fluconazole Study Group. Impact of fluconazole prophylaxis on fungal colonization and infection rates in neutropenic patients. J Antimirob Chemother 2000; 46:1001–1008.
   PubMed Web of Science ®Google Scholar
• Meunier F. Therapy of systemic candidiasis. Mycoses 1994; 37:52–55.
   Web of Science ®Google Scholar
• Bodey GP, Mardani M, Hanna HA, Baktour M, Abbas J, Girgawy E, Hachem RY, Kontoyiannis DP, Raad II. The epidemiology of Candida glabrata and Candida albicans fungemia in immunocompromised patients with can-cer. Am J Med 2002 ; 112:380–385.
   PubMed Web of Science ®Google Scholar
• Tortorano AM, Rigoni AL, Biraghi E, Prigitano A, Viviani M A and the FIMUAECMM candidaemia study group. The Europian Confederation of Medical Mycology (ECMM) survey of candidaemia in Italy:antifungal susceptibility patterns of 261 non-albicans Candida isolates from blood. J Antimicro Chemother 2003; 52:679–682.
   PubMed Web of Science ®Google Scholar
• Krcmery V, Barnes AJ. Non-albicans Candida species causing fungaemia:pathogenicity and antifungal resistance. J Hosp Infect 2002; 50:243–260.
   PubMed Web of Science ®Google Scholar
• Myokin Y, Kyo T, Fujihara M, Sug-ata T, Mikami Y. Clinical significance of breakthrough fungemia caused by azole-resistant Candida tropicalis in patients with hematologic malignancies. Haematologica 2004 ; 89:378–380.
   Web of Science ®Google Scholar
• Ribeiro P, Sousa AB, Nunes O, Aveiro F, Fernandes JP, Gouveia J. Candidaemia in acute leukemia pa-tients. Support Care Cancer 1997; 5:249–251.
   PubMed Web of Science ®Google Scholar
• Richardson MD, Kokki MH. Diag-nosis and prevention of fungal infection in the immunocompromised patient. Blood Rev 1998; 12:241–254.
   PubMed Web of Science ®Google Scholar
• Mitsutake K, Miyazaki T, Tashiro T, Yamamoto Y, Hakeya H, Otsubo T, Kawamura S, Hossain MA, Noda T, Hirakata Y, Kohno S. Enolase antigen, Mannan antigen, CandTec antigen and 8-glucan in patients with candidemia. J Clin Microbiol. 1996; 34:1;918–1921.
   Google Scholar
• Tortorano AM, Biraghi E, Astolfi A, Ossi C, Tejada m, Farina C, Perin S, Bonaccorso C, Cavanna C, Raballo A, Grossi A; FIMUA Candidemia Study Group. European Confederation of Medical Mycology (ECMM) prospective survey of candidaemia:report from one Italian region. J Hosp Infect 2002; 51:297–304.
   PubMed Web of Science ®Google Scholar
• Pappas PG, Rex JH, Sobel JD, Filler SG, Dismukes WE, Walsh TJ, Edwards JE. Guidelines for treatment of candidiasis. Clin Infect Dis 2004, 38:161–189.
   PubMed Web of Science ®Google Scholar
• Al-Jasser AM, El-Khizzi NA. Distribution of Candida species among bloodstream isolates. Saudi Med J 2004; 25:566–569.
   PubMed Web of Science ®Google Scholar
• Pagano L, Mele L, Fianchi L, Me-lillo L, Martino B, D’Antonio D, Tosti ME, Posteraro B, Sanguinetti M, Trape G, Equitani F, Carotenuto M, Leone G. Chronic disseminated candidiasis in patients with hematologic malignancies. Clinical features and outcome of 29 episodes. Haematologica 2002; 87:535–541.
   PubMed Web of Science ®Google Scholar
• Marr KA, Seidel K, White TC, Bow-den RA. Candidemia in allogeneic blood and marrow transplant recipients:evolution of risk factors after the adoption of prophylactic fluconazole. J Infect Dis 2000; 181:309–316.
   PubMed Web of Science ®Google Scholar
• Ellis M, Hedstrom U, Jumaa P, Bener A. Epidemiology, presentation, management and outcome of candidemia in a tertiary care teaching hospital in the United Arab Emirates, 1995-2001. Med Mycol 2003; 41:521–528
   PubMed Web of Science ®Google Scholar
• Al Hedaithy SS. The yeast species causing fungemia at a university hospital in Riyadh, Saudi Arabia during a 10-year period. Mycoses 2003; 46:293–298.
   Web of Science ®Google Scholar
• Abbas J, Bodey GP, Hanna HA, Mardani M, Girgawy E, Abi-Said D, Whimbey E, Hachem R, Raad I. Candida krusei fungemia. An escalating serious infection in immunocompromised patients. Arch Intern Med 2000; 160:2659–2664.
   PubMed Web of Science ®Google Scholar
• Kami M, Machida U, Okuzumi K, Matsumura T, MoriSi S, Honi A, Kashima T, Kanda Y, Takaue Y, Sakamaki H, Hirai H, Yoneyama A, Mutou Y. Effect of fluconazole prophylaxis on fungal blood cultures:an autopsy-based study involving 720 patients with haematological malignancy. Br J Haematol 2002; 117:40–46.
   PubMed Web of Science ®Google Scholar
• Nucci M, Colombo AL. Risk factors for breakthrough candidemia. EurJ Clin Microbiol Infect Dis 2002; 21:209–211.
   PubMed Web of Science ®Google Scholar
• Specchia G, Pastore D, Montagna MT, Carluccio P, Ciuffreda L, Rizzi R, Liso A. Fungemia in acute leukemia patients:a single institution’s experience. New Microbiol 2004; 27:407–410.
   PubMed Web of Science ®Google Scholar
• Pfaller MA, Messer SA, Boyken L, Tendolker S, Hollis RJ, Diekema DJ. Geographic variation in the susceptibilities of invasive isolates of Candida glabrata to seven systemically active antifungal agents:a global assessment from the ARTEMIS Antifungal Surveillance Program conducted in 2001 and 2002. J Clin Microbiol 2004; 42:3142-3146.
   Google Scholar
• Yang, YL, Ho YA, Cheng HH, Ho M, Lo HJ. Susceptibilities of Candida species to amphotericin-B and fluconazole:the emergence of fluconazole resistance in Candida tropicalis. Infect Control Hosp Epidemiol 2004; 25:60–64.
   PubMed Web of Science ®Google Scholar
• Sallah S, Wan JY, Nguyen NP, Vos P, Sigounas G. Analysis of factors related to the occurrence of chronic disseminated candidiasis in patients with acute leukemia in a non-bone marrow transplant setting. A follow up study. Cancer 2001; 92:1349–1353.
   Google Scholar
• Anaissie EJ. Opportunistic mycoses in the immunocompromised host:experience at a cancer centre and review. Clin Infect Dis 1992; 14:43–53.
   PubMed Web of Science ®Google Scholar
• Walsh TJ, Finberg RW, Arndt C, Hiemenz J, Schwartz C, Bodensteiner D, Pappas P, Seibel N, Greenberg RN, Dummer S, Schuster M, Holcenberg JS, Dismukes WE for the National institute of Allergy and Infectious diseases Mycoses Study Group. Liposomal amphotericin-B for empirical therapy in patients with persistent fever and neutropenia. N Engl J Med 1999; 340:764–771.
   Google Scholar
• Boucher HW, Groll AH, Chiou CC, Walsh TJ. Newer systemic antifungal agents:pharmacokinetics, safety and efficacy. Drugs 2004; 64:1997–2020.
   PubMed Web of Science ®Google Scholar
• Andriole VT. Current and future antifungal therapy:new targets for anti-fungal agents. J Antimicrob Chemother 1999:44:151–162.
   PubMed Web of Science ®Google Scholar
• Anaissie EJ, Rex JH, Uzun O, Vartivarian S. Predictors of adverse outcome in cancer patients with candidemia. Am J Med 1998; 104:238–245.
   PubMed Web of Science ®Google Scholar
• Schelenz S, Gransden WR. Candidaemia in a London teaching hospital:analysis of 128 cases over a 7-year period. Mycoses 2003; 46:390–396.
   Web of Science ®Google Scholar